VERV
Verve Therapeutics
VERV
VERV
Delisted
VERV was delisted on the 24th of July, 2025.
101 hedge funds and large institutions have $696M invested in Verve Therapeutics in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 32 increasing their positions, 21 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
10% more funds holding
Funds holding: 92 → 101 (+9)
2.37% less ownership
Funds ownership: 96.02% → 93.65% (-2.4%)
35% less capital invested
Capital invested by funds: $1.06B → $696M (-$368M)
Holders
101
Holding in Top 10
4
Calls
$3.87M
Puts
$201K
Top Buyers
| 1 | +$7.26M | |
| 2 | +$6.5M | |
| 3 | +$5.92M | |
| 4 |
Millennium Management
New York
|
+$5.68M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$5.26M |
Top Sellers
| 1 | -$31.4M | |
| 2 | -$16.5M | |
| 3 | -$15.7M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$7.08M |
| 5 |
Rafferty Asset Management
New York
|
-$4.22M |